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Purpose: The purpose of the present study was to evaluate the acute and subacute toxicity of the 
aqueous leaf extract of Combretum molle. 
Methods: The acute toxicity of the extract was evaluated in rats. The animals were orally administered 
with doses ranging from 2000 to 8000 mg/kg and observed continuously for the first 4 h, then  hourly for 
the next 24 h, and finally, 6-hourly for 72 h. Control animals received orally normal saline. The rats were 
observed carefully for mortality, pain as well as respiratory movements. For subacute toxicity, 6 groups 
of 6 rats (3 male and 3 female) each received intraperitoneally, normal saline (control), 400, 600, 800, 
1000 and 1200 mg/kg of the extract, respectively, thrice daily for 15 days. At the end of the treatment 
period, the animals were sacrificed and their organs (liver, heart and kidney) removed for macroscopic 
examination. 
Results: For the acute toxicit test, no death and signs of poisoning were observed in the treated groups. 
In the subacute tstudy, LD50 in the rats after intraperitoneal administration was 700 mg/kg (456 - 896, 95 
% confidence interval). The clinical signs of poisoning (motor difficulties, decreased respiratory rate, and 
tremor preceding death) were observed, suggesting overt toxicity throughout the neuromuscular system. 
However, histological examination of vital organs showed normal architecture suggesting no 
morphological abnormalities in the heart, kidney and liver. 
Conclusion: The results show that the aqueous leaf extract of C. molle is moderately toxic when given 
intraperitoneally. 
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INTRODUCTION 
 
Combretum molle is a shrub or small, 
graceful, deciduous tree, 3 - 13 m high, with a 
crooked or lean trunk, occasionally swollen at 
the base, and up to 30 cm in diameter. It is 
found especially in savannah vegetation that 
cuts across from Senegal to West Cameroon, 
but generally exists in tropical Africa [1]. 
Traditional healers throughout Africa use this 
specie of Combretaceae for many medicinal 
purposes. These include treatment of fever, 
headaches, abdominal disorders, abdominal 
pains, gallstones, diarrhoea, dysentery, 
gastric ulcers, bilharziasis, hookworm, 
nosebleeds, sore throats, colds, chest 
coughs, pneumonia, conjunctivitis, 
dysmenorrhoea, infertility in women, venereal 
diseases including syphilis, and earache. It 
has also been used for the treatment of 
leprosy, scorpion and snake bitesas well as 
toothache, heart diseases, backache, 
jaundice, stomach, gastric problems, 
constipation and general weakness. Other 
uses include treatment of swelling caused by 
mumps and cleansing of the urinary system. 
Species of Combretaceae have also been 
used as food supplement for babies [2-5].  
 
Some studies have been performed on the 
biological activities of C. molle. Its leaf has 
anti-asthmatic and anti-tussive activities [6]. 
The plant induces considerable reduction in 
the variation of breathing amplitudes. 
Furthermore, the extract probably contains 
anticholinesterase substances as it exerted 
non-competitive inhibition of 
acetylcholinesterase with a Michaelis-Menten 
constant (KM) of 192 µM and velocity at 
maximal concentration of substrate (Vmax) of 
4444 µM/min [7]. McGaw et al [8] found C. 
molle to have both anti-inflammatory and 
antischistosomal activities which may justify 
the traditional use of the plant for the 
treatment of malaria and pain. 
 
Despite its long-time and varied uses, there 
are no data on the safety profile of the plant. 
This study was undertaken to determine the 
acute and subacute toxicity of the aqueous 
leaf extract of Combretum molle given orally 





Preparation of aqueous extract 
 
The plant material (C. molle leaves) was 
collected in December 2009 from Korhogo, in 
northern Ivory Coast, and authenticated by 
Professor Assi L Aké of the National Floristic 
Garden (University of Cocody-Abidjan). A 
voucher specimen (no. 6129) was deposited 
at the National Floristic Garden (University of 
Cocody-Abidjan). The dried leaves were 
powdered in a mortar and about 100 g of the 
powder extracted with 2 L of distilled water 
for 48 h on a hot plate. The mixture was 
sequentially filtered through a cheese cloth, 
cotton wool and Whatman filter paper no.1, 
respectively. The filtrate obtained was 
concentrated under reduced pressure, using 





Adult Sprague Dawley (SD) rats used for the 
study (36 males and females each), weighing 
180 - 200 g, were obtained from the animal 
house of the Physiology Department, 
University of Cocody-Abidjan, Ivory Coast.  
 
The experimental procedures and protocols 
used in this study were approved by Ethical 
Committee of Health Sciences of the 
university [9,10]. The animals were housed in 
plastic cages (47×34×18 cm) in an air-
conditioned environment with 6 rats in each 
cage. The temperature of the environment 
was 25 ± 2 ºC with a 12 h light-dark cycle. 




The animals were divided into a control group 
and four treatment groups (2000, 4000, 6000 
and 8000 mg/kg of extract), each group 
consisting of six animals. The repeat-dose 
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oral toxicity study was carried out according 
to OECD guideline 407 [11]. The control 
group (Group 1) received orally, normal 
saline (0.9% NaCl)) while Groups 2 to 5 
received 2000, 4000, 6000 and 8000 mg/kg 
body weight, respectively. Each treated group 
received the aqueous extract orally and 
clinical signs and symptoms were observed 
continuously for the first 4 h, then hourly for 
the next 24 h, and finally, 6-hourly for 72 h 
[12]. All the surviving animals were sacrificed 
after being anesthesized with sodium 
entobarbital. 
 
Subcute toxicity test 
 
The animals were divided into six groups of 
six animals each. The treatments were given 
by intraperitoneal injection. Group 1 served 
as control and received normal saline, while 
Groups 2 to 6 received 400, 600, 800, 1000 
and 1200 mg/kg body weight, respectively, of 
the extract. Each group received the 
specified treatment dose thrice daily for 15 
days. The animals were observed every 2 
hours for toxic symptoms, signs of poisoning 
and mortality over a period of 30 days. The 
organs of the dead animals (liver, heart and 
kidney) were removed for macroscopic 
examination. 
 
Determination of lethal dose (LD 50) 
 
The mortality rate of the animals for each 
dose was computed [13,14]. The arithmetical 
method of Karber was used for the 
determination of LD50 [15]. The interval mean 
of the dead animals in each group of animals 
was used as well as the difference between 
doses for the same interval. The product of 
interval mean and dose difference was 
obtained. The sum of the product was divided 
by the number of animals in a group and the 
resulting quotient was subtracted from the 
least lethal dose in order to obtain LD50 value 
(Eq 1).  
 
LD50 = LD - Σab/N ………………………. (1)  
 
where LD is the apparent lethal dose of all 
the groups, N is the number of animals in 
each group, a is the dose difference and b 




For post-mortem, the rats were dissected and 
careful examination of the organs, liver, 
kidneys and heart were carried out. Tissue 
samples were fixed in 10 % formalin and 
dehydrated overnight using upgraded ethanol 
series and embedded in paraffin blocks. 
Ultrathin sections were de-waxed by xylene, 
hydrated through a degraded ethanol series, 
and stained with haematoxylin and eosin. A 
pathologist, blinded to the treatments, 
performed the histopathologic examination 
with an optical microscope [Nikon Eclipse 
E600, USA (x 400). Sections were assigned 




The LD50 values were computed by probit 
analysis with a calculator. One-way analysis 
of variance (ANOVA) with Tukey post hoc 
test was applied to evaluate significant 
differences between groups with Instat 
Statistical Package (Graph Pad Software). 





Acute toxicity   
 
Oral administration of the aqueous extract of 
C. molle (2000 to 8000 mg/kg) did not 
produce significant changes in behavior, 
breathing, cutaneous effects (irritation, 
ulceration, caustic injuries and skin rashes), 
sensory nervous system responses, and 
gastrointestinal effects in the animals. No 
deaths occurred in any of the groups during 
the entire period of treatment. Also, no 
mortality was observed after oral ingestion of 
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Sub-acute toxicity  
 
In the animals that received the extract 
intraperitoneally, abdominal muscle 
contractions and ataxia were observed, and 
these persisted for a few hours. At the 6th h, the 
animals became drowsy and less responsive to 
stimuli. Some of the animals died and mortality 
was as well as the severity of the toxic effects 
were dose-related (Table 1). However, at the 
24th h, most of the survivors had recovered from 
these symptoms. LD50 of C. molle in rats was 
determined to be 700 mg/kg (range: 456 - 895 
mg/kg, 95% confidence interval) after 
intraperitoneal injection. The results are given in 
Tables 2 and 3. 
 
 
Table 1: Mortality rate (%) of rats in acute toxicity test 
 
  Period (h)    Treatment 
group 0-6 6-8 8-10 10-12 12-22 22-24 
Control  0 0 0 0 0 0 
400 mg/kg  0 0 0 0 0 0 
600 mg/kg  0 0 0 16,7±2.0 33.3±1.0 33.3±4.0 
800 mg/kg  0 16.7±2.0** 16.7±2.0** 33.3±1.0** 33.3±1.0** 83.3±9.0** 
1000 mg/kg  0 33.3±3.0 
a 33.3±3.0 a 50.0±9.0 a 66.7±4.0 a 83.3±5.0 a 
1200 mg/kg  16.7±3.0 83.3±1.0 
a* 50.0±5.0 a* 66.7±4.0 a* 83.3±9.0 a* 100 
** p < 0.01 compared with 600 mg/kg and 800 mg/kg groups; a p < 0.001 compared with 1000 mg/kg group and 600 
mg/kg groups; a* p < 0.001 compared with 1200 mg/kg and 1000 mg/kg groups 
 
Table 2: Mortality rate in subacute toxicity test, and corrected values after intraperitoneal administration of the 
extract 
Treatment group Dose (mg/ml) Log dose Mortality rate (%) Corrected (%) 
Control  Vehicle  0 0 
400 mg/kg  400 
2.60 
0 4.17 
600 mg/kg  600 2.78 33.33 33.33 
800 mg/kg  800 2.90 83.33 83.33 
1000 mg/kg  1000 3 83.33 83.33 
1200 mg/kg  1200 3.08 100 95.83 
Corrected % formula: For 0% dead, 100(0.25/n) [15]. 







Number of dead 
animals  
Mean mortality between 
two consecutive doses  
(b)  
Probits 
(a x b) 
Control 0 0 0 0 
400 mg/kg 400 0 0 0 
600 mg/kg  200 2 1 200 
800 mg/kg  200 5 3,5 700 
1000 mg/kg  200 5 5 1000 
1200 mg/kg  200 6 5,5 1100 
Note: Sum of the product = 2100; LD50 = LD - Σab/N; N = 6; Σab=3000; Least lethal dose = 600; LD50 = 1200-
3000/6 = 1200 - 500 = 700 mg/kg.  
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Histopathological results  
 
Histopathological data on the liver, heart and 
kidney of the rats are shown in Figs 1 – 3, 
respectively. No changes were observed in 
the heart and kidney of the rats following 
extract administration. However, Fig 1b 
shows cell infiltration of the portal vein, 
















       





Herbal medicines have received great 
attention as an alternative to clinical therapy 
Fig 1a:  Histopathology of normal rat  
Normal liver (control) with normal parenchymal 
cells. The section showing structure of liver with 
sheets of hepatocytes arranged around central 
vein. Hepatocytes, sinosoids appeared normal, 
stained with haematoxyline-eosin (400 x 
magnification).  
 
Fig 1b:  Histopathology of rat liver treated with 
aqueous extract (1000 mg/kg of Combretum molle 
extract). V = portal tract; A = Hepatic duct; B= 
Artery. The section showing structure of liver with 
an infiltration of cells through the portal vein, 
stained with haematoxyline-eosin (400 x 
magnification).  
 
Fig 2a:  Representative photomicrograph of 
cardiac tissue (control). Section showing normal 
myofibrilar organization and cytoplasmic 
vacuolation. stained with haematoxyline-eosin 
(400 x magnification). 
 
Fig 2b: Histopathology of rat heart in C.molle 
treated group (1200mg/kg body weight). 
Cytoplasmic vacuolation and myofibrilar 
organization were normal, stained with 
haematoxyline-eosin (400 x magnification). 
Figure 3a: Histopathology kidney after 
administration of 0.9 % saline solution Section 
showing normal glomerulus and distal 
convoluted tubules (haematoxylin and eosin 
staining, magnification x 400) 
 
Figure 3b:  Histopatjhology of kidney after 
administration of 1200 mg/kg of C.molle. There was 
no damage to glomerulus and distal convoluted 
tubules (haematoxylin and eosin staining, 
magnification x 400).  
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leading to increasing demand. Experimental 
screening method is, therefore, important in 
order to ascertain the safety of these herbal 
remedies [17]. A previous study showed the 
antiantiasthmatic effect of C. molle aqueous 
extract at 7.14 mg/kg body weight in rabbit 
[18]. In the acute toxicity study, there was no 
mortality observed even at a maximum oral 
dose of 8000 mg/kg of the aqueous extract. 
Also, no changes in the behavior and in the 
sensory nervous system responses were 
observed. No death or signs of poisoning 
were observed after oral administration of the 
extract; suggesting oral doses of C. molle are 
not toxic. However, histological analysis 
showed infiltration of inflammatory cells at the 
level of the portal vein in the liver. 
Inflammation was probably due to passive 
immune response to the extract 
. 
The maximum tolerated dose (MTD) obtained 
intraperitoneally was 400 mg/kg body weight. 
The clinical signs of toxicity observed after 
intraperitoneal administration, such as motor 
difficulties, decreased respiratory rate, and 
tremor preceding death, suggest overt toxicity 
throughout the neuromuscular system. The 
LD50 (intraperitoneal injection) of C.molle 
extract in rats was 700 mg/kg; indicating that 
the plant is moderately toxic [19].  
Macroscopic analysis of the target organs of 
the treated animals (liver, heart, and kidney) 
did not show significant changes in color and 




Our findings did not show any damage to the 
kidney and heart of rats following oral 
administration of high doses of C. molle 
extract. Furthermore, no mortality was 
observed following oral administration. 
However, the extract seems to be moderately 
toxic after intraperitoneal administration. It 
also induced infiltration of inflammatory cells 
into the portal vein of the liver; a 
phenomenon that could compromise the 
medicinal use of this plant in folk medicine. 
However further studies are necessary, such 
as hematological assay and more in-depth 
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